Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krieg

Showing results (21-30 of 722) with videos related to

Pageof 73
Sort By:
The Journal of Laboratory and Clinical Medicine|August 1, 1996
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAA M Krieg
Nature Reviews. Drug Discovery|June 10, 2006
Therapeutic potential of Toll-like receptor 9 activationArthur M Krieg
Journal for Immunotherapy of Cancer|September 19, 2025
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunityArthur M Krieg
Trends in Microbiology|March 19, 1999
CpG DNA: a novel immunomodulatorA M Krieg
Springer Seminars in Immunopathology|August 17, 2000
Signal transduction induced by immunostimulatory CpG DNAA M Krieg
The Journal of Clinical Investigation|May 4, 2007
Development of TLR9 agonists for cancer therapyArthur M Krieg
Nature Biotechnology|March 9, 2007
Toll-free vaccines?Arthur M Krieg
The Lancet. Oncology|May 15, 2022
Awake craniotomy as a mandatory part of the armamentarium of surgical neuro-oncologistsSandro M Krieg
Nature Immunology|April 19, 2007
TLR9 and DNA 'feel' RAGEArthur M Krieg
Nature Biotechnology|May 12, 2019
Mind the gap!Arthur M Krieg
Pageof 73

Showing results (21-30 of 722) with videos related to

Sort By:
Pageof 73
The Journal of Laboratory and Clinical Medicine|August 1, 1996
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAA M Krieg
Nature Reviews. Drug Discovery|June 10, 2006
Therapeutic potential of Toll-like receptor 9 activationArthur M Krieg
Journal for Immunotherapy of Cancer|September 19, 2025
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunityArthur M Krieg
Trends in Microbiology|March 19, 1999
CpG DNA: a novel immunomodulatorA M Krieg
Springer Seminars in Immunopathology|August 17, 2000
Signal transduction induced by immunostimulatory CpG DNAA M Krieg
The Journal of Clinical Investigation|May 4, 2007
Development of TLR9 agonists for cancer therapyArthur M Krieg
Nature Biotechnology|March 9, 2007
Toll-free vaccines?Arthur M Krieg
The Lancet. Oncology|May 15, 2022
Awake craniotomy as a mandatory part of the armamentarium of surgical neuro-oncologistsSandro M Krieg
Nature Immunology|April 19, 2007
TLR9 and DNA 'feel' RAGEArthur M Krieg
Nature Biotechnology|May 12, 2019
Mind the gap!Arthur M Krieg
Pageof 73